Posts Tagged ‘ Medtronic ’

Industry-Backed Patient Group Supports Surgery, Treatment

Sep 26th, 2012 | By
Industry-Backed Patient Group Supports Surgery, Treatment

September 26, 2012 ~ With all of the news about complications resulting from transvaginal synthetic surgical mesh, and the thousands of product liability lawsuits filed in state and federal court, one might assume industry would push back. That’s exactly what is happening. The Pelvic Floor Disorders Alliance is launching a Public Awareness Campaign, “Break Free
[continue reading...]



Coming Up: FDA Expert Panel Weighs in on Metal Hips

Jun 20th, 2012 | By
Coming Up: FDA Expert Panel Weighs in on Metal Hips

Next Wednesday, June 27 and Thursday, June 28, the U.S. Food and Drug Administration (FDA) will convene one of its expert panels – this one on patient complications after a metal-on-metal hip implant. It is a gathering called by the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee within the FDA. The
[continue reading...]



Senate Passes FDA Funding Bill Minus Major Patient Safety Provisions

May 24th, 2012 | By
Senate Passes FDA Funding Bill Minus Major Patient Safety Provisions

May 24, 2012 ~ The U.S. Food and Drug Administration (FDA) is one step closer to being funded for the next five years in a bi-partisan vote considered good for the FDA and industry – but what about patients? The Food and Drug Administration Safety and Innovation Act passed on an unusual bi-partisan vote,  96-1,
[continue reading...]



Industry Doesn’t Want Medical Device Tax, GOP Freshmen Help

Feb 9th, 2012 | By
Industry Doesn’t Want Medical Device Tax, GOP Freshmen Help

An article in DOTmedNews reports that GOP freshmen are aligning with industry to oppose a 2.3 percent excise tax on the medical device industry set to go into effect January 2013. Industry says it will hurt profits and drive jobs and innovation oversees. As the deadline gets closer, the opposition is growing louder. Monday, February
[continue reading...]



More Monitoring of Medical Device Implants After Market

Dec 18th, 2011 | By
More Monitoring of Medical Device Implants After Market

Artificial hips that fail, surgical mesh that injures – the New York Times reports (here) on December 14, 2011, that amid the growing number of problems with medical devices a bipartisan bill was introduced in the U.S. Senate that would require device makers follow the life of their products after they’re approved for sale. Share
[continue reading...]



Medtronic Pays $23 Million to Settle Doctor Kickback Charges

Dec 18th, 2011 | By
Medtronic Pays $23 Million to Settle Doctor Kickback Charges

Medtronic is the world’s top maker of medical devices and it didn’t get that way without help. The U.S. Department of Justice accused the Minnesota-based company of having friends in high places – Share this:



Did Medtronic Sell an Unsafe Product?

Nov 12th, 2011 | By

NOVEMBER 12, 2011 – Fridley, Minnesota is home to Medtronic, the largest medical device company, and an article in the Star Tribune, November 12, Saturday, asks Did Medtronic sell an unsafe product?  (here) Share this:



FDA: Medical Device Complications Growing Faster than Industry

Nov 8th, 2011 | By
FDA: Medical Device Complications Growing Faster than Industry

Understanding Barriers to Medical Device Quality is the name of an FDA report issued October 31 by the Center for Devices and Radiological Health (CDRH) and the Food and Drug Administration (FDA) in an attempt to get a handle on why the medical device industry is putting out poorly made, defective medical devices that are
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.